Azzad Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Azzad Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-119,157	Closed	-$13.6K	–	327
2018 Q4	$13.6K	Buy	119,157 +89,177	+297%	+$58.5K	﹤0.01%	296
2018 Q3	$51K	Hold	29,980	–	–	0.01%	322
2018 Q2	$52.2K	Sell	29,980 -2,669	-8%	-$4.61K	0.02%	305
2018 Q1	$59.7K	Hold	32,649	–	–	0.02%	293
2017 Q4	$72.8K	Buy	+32,649	New	+$81.2K	0.02%	282
2017 Q3	–	Sell	-11,765	Closed	-$52.4K	–	296
2017 Q2	$52.4K	Buy	+11,765	New	+$48.5K	0.02%	287

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Azzad Asset Management's SGYP Position: Q1 2019 in Review

Azzad Asset Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 119,157 shares — an estimated $13.6K sold.

Azzad Asset Management first reported a position in SGYP in Q2 2017 and held it in 6 quarters. The position peaked at $72.8K in Q4 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Azzad Asset Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Azzad Asset Management sold 119,157 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $13.6K.
Azzad Asset Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2017 and held it in 6 quarters.
Azzad Asset Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $72.8K in Q4 2017.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Azzad Asset Management's 13F filing for Q1 2019, filed 1 Apr 2024.